Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University.

Slides:



Advertisements
Similar presentations
Laskjfoaisufäüaosfnöaskliruqäwej Literature CBM submissions under the Biological Weapons Convention, Germany, ,
Advertisements

BIOETHICS: THE SUBJECT, PURPOSE AND OBJECTIVES OF THE HEALTH CARE SYSTEM. BIOETHICS OF BIOMEDICAL EXPERIMENTS. INTERNATIONAL DOCUMENTS ON BIOETHICS AND.
Regional Centers of Excellence Academic defense against bioterrorism.
The scientist as a responsible member of society, ethical issues in research, and the environmental and societal impacts of scientific research On Being.
NC State University - March David Drooz1 USA PATRIOT Federal anti- terrorism law Effective October 26, 2001 December 31, 2005, sunset for some of.
1 Recent Bioterrorism Legislation Madelyn Miller August 2003.
Copyright 2010, The World Bank Group. All Rights Reserved. Background and governance Part 1 Crime, Justice & Security Statistics Produced in Collaboration.
Biological and Radiological Regulatory Concerns for Research Administrators Megan G. Marks, Ph.D. Biological and Radiological Safety Manager Carnegie Mellon.
Brian J. Gorman, M.Sc., J.D. Towson University, Maryland Presentation for The National Academies’ Committee on Scientific Communication and National Security.
“The Life Sciences, Biosecurity, and Dual Use Research” Designed by: Brian Rappert Malcolm Dando University of Exeter Bradford University Marie Chevrier.
DUAL USE RESEARCH OF CONCERN US Government (USG) Policy for Institutional Oversight of Life Sciences 10/13/2014.
1 The Basic Problem: Dual-Use Research Kathryn Nixdorff Department of Microbiology and Genetics Darmstadt University of Technology, Germany.
The International Regulation of Biotechnology Lecture No. 19 Further Inf. For further information and video link please click on the right buttons in the.
Addressing Synthetic Biology and Biosecurity
Principles and Practices of Biosafety Environmental Health and Safety San Diego State University.
Dual-Use: The Fink Report
The Select Agent Laboratory: at the intersection of research, preparedness and safety Nancy Connell,PhD Professor and Vice-chair for Research Department.
Draft Lecture No 14 By Malcolm Dando. I. Outline The concept of dual-use Slides The Fink Committee Report –A. Objective and structure of the report.
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
The International Regulation of Biotechnology Lecture No. 19.
Overview of the Lectures in the Education Module Resource Lecture No. 1.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
O PERATING A BSL-3 F ACILITY IN K OREA T HE IVI E XPERIENCE INTERNATIONAL WORKSHOP ON ANTICIPATING BIOSECURITY CHALLENGES OF THE GLOBAL EXPANSION OF HIGH.
Biosafety and recombinant DNA technology. Involves.... Experiments involving the construction or use of GMOs should be conducted after performing a biosafety.
Safety Review and Approval Process for Research Proposals Robert Emery, DrPH, CHP, CIH, CBSP, CSP, CHMM, CPP, ARM Vice President for Safety, Health, Environment.
Division of Emerging and Transfusion Transmitted Diseases Bioterrorism Preparedness Initiatives Hira L. Nakhasi, Ph.D.
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Pakistan National Accreditation Council. Biorisk Management.
Research Protocol Registration at WUStL Institutional Biological and Chemical Safety Committee/ Environmental Health and Safety Joe Kanabrocki Biological.
Export Control Presented by Research and Graduate Studies Elizabeth Peloso.
RS–IAP-ICSU, September 2006 NSABB National Science Advisory Board on Biosecurity Dual Use Research: Scope, Criteria and Communication.
US biosafety experiences during the last two decades: Lessons and achievements PETER PALESE MOUNT SINAI SCHOOL OF MEDICINE, New York BIOSECURITY, ISTANBUL,
Dual-Use Research: A Double Challenge for International Science Henry Metzger, MD Scientist Emeritus, NIAMS, NIH.
1 Biosecurity in the International Futures Programme of the OECD David B. Sawaya OECD International Futures Program Matrahaza,
ACADs (08-006) Covered Keywords Commission, regulation, advisory, standards. Description This presentation provides general information about each of the.
0 UMOR Strengthening the Culture of Compliance While Minimizing Faculty Burden Lois Brako Assistant Vice President for Research – Regulatory and Compliance.
Local Recombinant DNA Oversight Mass Biotech Council Series Enforcement of the Cambridge Recombinant DNA Technology Ordinance Cambridge Biosafety Committee.
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
BSAF-BIONET Meeting Robert J. Hashimoto, CBSP University of California, Berkeley October 2, 2009.
Dual Use Research of Concern Boston University and Boston Medical Center.
1 WHO Communicable Diseases, Surveillance & Response SARS Diagnostics and Laboratory Needs: the WHO Perspective C.E. Roth Dangerous and New Pathogens Global.
“History is a set of lies agreed upon.” Napoleon Bonaparte.
Biosafety/ Biosecurity in Georgia Lela Bakanidze, Ph.D. National Center for Disease Control and Medical Statistics of Georgia Scientific Networking and.
Dual Use Research of Concern (DURC) University of North Carolina at Greensboro.
A Review of H.R. 3448: Public Health Security and Bioterrorism Preparedness Act of 2002 Harry Enoch, Ph.D. Director of Environmental, Health & Safety University.
Material Control & Accountability
Humans and the Microbial World Chapter 1. What is a Microorganism? 1.Definition 2.Prokaryotic or Eukaryotic? 3.Unicellular or Multicellular?
National Security and Biological Research: Where are the Boundaries? Ronald Atlas Co-director Center for Deterrence of Biowarfare and Bioterrorism Graduate.
World Health Organization Life science research: opportunities and risks for public health Ottorino Cosivi Department of Epidemic and Pandemic Alert and.
Biosecurity at CDC pre & post 9/11 Jonathan Y. Richmond, PhD Director Office of Health and Safety CDC, Atlanta.
Mid – Late 1970’s Emergence of recombinant DNA technology Concerns among both scientific community and general public:  Public health and safety  Environmental.
The Integrated National Biodefense Portfolio Initiative “One-Portfolio” Chemical Biological Defense Acquisition Initiatives Forum (CBDAIF) May 6, 2009.
Dual Use Research, Bioweapons and Biosecurity Iris Hunger Research Group for Biological Arms Control Carl Friedrich von Weizsäcker Centre for Science and.
Royal Irish Academy Briefing Bert Rima 109/01/2016.
Promotions on the Physician Scientist/Basic Science Investigator Track Larry L. Swift, Ph.D. Vice Chair for Faculty Affairs Department of Pathology, Microbiology.
INTERNATIONAL SCIENCE AND ENGINEERING FAIR Rules and Guidelines 2016.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
1 The Argument for Oversight: Developments in the US John Steinbruner University of Maryland Controlling Dangerous Pathogens Project: Regional Workshop.
Objectives  Define risk assessment as it relates to biosafety  Understand the risk assessment process and how to implement it  Discuss risk factors.
Ratification of BWC BWC Expert Group, Republic of Korea Compendium of National Activities in Korea: Measures to Improve Biosafety and Biosecurity Hei Chan.
NIH Guidelines for Research Involving rDNA Molecules (NIH Guidelines) and Institutional Biosafety Committees.
The National Oversight of Bioscience Researches in Korea : Biosafety & Biosecurity WK Seong, CK Yoo, JK Lee, JB Ahn, and TJ Son Division of Biosafety Evaluation.
Chapter 22 REGULATORY AND ADVISORY AGENCIES. Introduction 2.
Dual Use Research of Concern
Stanford University Dual Use Research of Concern in the Life Sciences
Biosafety at Swinburne
University of Greenwich
Agenda 11/20 Bioterrorism talk Bioterrorism project
Promotions on the Physician Scientist/Basic Science Investigator Track
Biotechnology Training & Researching in University of Natural Science
Presentation transcript:

Bioterrorism: Changing Priorities in Medical Training and Research Richard Coico Professor and Chairman Department of Microbiology & Immunology City University of New York Medical School Past-President, Association of Medical School Microbiology & Immunology Chairs ( )

Bioterrorism-Related Resources for Medical & Graduate Education Programs  What should we teach medical students?  What should we teach graduate students?  Who should decide how to answer these questions?

Medical School Pre-Clinical Curriculum National consensus reached among medical educators responsible for teaching microbiology, immunology & infectious diseases under the auspices of AMSMIC: Guidelines for Pre-Clerkship Medical School Bioterrorism Curricula Richard Coico, Elizabeth Kachur, Viera Lima, and Stanley Lipper Academic Medicine, 2004 (in press)

Medical School Clinical Curriculum Guidelines for curriculum content related to bioterrorism were developed by a multi-disciplinary group of experts convened by the AAMC: Training Future Physicians About Weapons of Mass Destruction: Report of the Expert Panel on Bioterrorism Education for Medical Students

Graduate Education American Society for Microbiology

Medical Research: Impact of the PATRIOT Act Providing Appropriate Tools Required to Intercept and Obstruct Terrorism (PATRIOT) Act Date Passed: Oct. 25, 2001 Part of the Act expands restrictions on the possession, use and access to biological agents, toxins and delivery systems.

PATRIOT Act  The Act requires registration not only of the transport, but also the possession of "select agents.”  The Act expands the government's ability to restrict access to hazardous agents.

PATRIOT Act  Allows for prosecution, fines, or imprisonment of any person who knowingly possesses any biological agent that is not justified by prophylactic, protective, bona fide research, or other peaceful purpose; and  Makes it a crime to possess select agents for persons under indictment, who have been imprisoned for more than a year, fugitives from justice, unlawful users of a controlled substance, illegal aliens, aliens not admitted for permanent residence from certain terrorist countries where trade is controlled by the Export Administration Act, persons who have been adjudicated as a "mental defective" or have been committed to a mental institution, or those who have been dishonorably discharged from the Armed Services.

Select Agents  Viruses (e.g. Smallpox, Ebola, Marburg)  Bacteria (e.g. Bacillus anthracis, Yersinia pestis)  Fungi (e.g. Coccidioides, Phakopsora)  Toxins (e.g. Botulinum neurotoxins, Ricin)  Prions (e.g. Bovine spongiform encephalopathy)

Medical Research: Fink Committee Report  The government should not attempt to regulate scientific publishing but trust scientists and journals to screen their papers for security risks  The U.S. should facilitate a new International Forum on Biosecurity to encourage the adoption of similar measures around the world.  Experiments of concern involving “dual use” pathogens should be approved by the IBCs that already oversee recombinant DNA research at U.S. institutions.

Experiments of Concern 1.Would demonstrate how to render a vaccine ineffective. This would apply to both human and animal vaccines 2. Would confer resistance to therapeutically useful antibiotics or antiviral agents. This would apply to therapeutic agents that are used to control disease agents in humans, animals, or crops.

Experiments of Concern 3.Would enhance the virulence of a pathogen or render a nonpathogen virulent. This would apply to plant, animal, and human pathogens. 4.Would increase transmissibility of a pathogen. This would include enhancing transmission within or between species.

Experiments of Concern 5.Would alter the host range of a pathogen. This would include making nonzoonotics into zoonotic agents. 6. Would enable the evasion of diagnostic and detection modalities. 7. Would enable the weaponization of a biological agent or toxin. This would include environmental stabilization of pathogens.

HHS Responds to Fink Committee Recommendations March, 2440: U.S. formally endorses Fink Report recommendation #4 to establish the National Science Advisory Board for Biosecurity. Mission: To improve biosecurity measures of legitimate biological research that could be misused to threaten the public/national security – so called “dual use” research.

Bioterrorism: Changing Priorities in Medical Training and Research  U.S. medical schools have installed curricular components related to bioterrorism.  Graduate biomedical education programs and biomedical research have both been impacted by the Patriot Act.  The National Science Advisory Board for Biosecurity will be a crucial resource for research oversight and policy guidelines related to dual use pathogens.